Ichiro Kinoshita

机构：Sapporo Medical University, Hokkaido University, Hokkaido University Hospital · ORCID：0000-0002-6694-8414

发表论文 298 篇 · 总被引 13221 次 · h-index 44

代表论文

• Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial (2024 · EClinicalMedicine · 被引 34)
• Trastuzumab deruxtecan in patients with human epidermal growth factor receptor 2–expressing salivary gland carcinoma: a pooled analysis of two phase I studies (2024 · Japanese Journal of Clinical Oncology · 被引 34)
• A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence (2023 · JAMA Oncology · 被引 19)
• Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer (2025 · Japanese Journal of Clinical Oncology · 被引 10)
• Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1 (2023 · International Journal of Clinical Oncology · 被引 8)
• Polymorphisms of the PD‐L1 gene 3′‐untranslated region are associated with the expression of PD‐L1 in non‐small cell lung cancer (2023 · Genes Chromosomes and Cancer · 被引 6)